Intelligence / Healthtech / New Clinical Trials
ClinicalLIVEUpdated 18 Nov 2026
New Clinical Trials
Clinical trials companies registered in the last 30 days, worldwide, with the sponsor, phase and countries.
Sources: ClinicalTrials.gov · Rebuilt weekly · Trials first posted in the window whose lead sponsor is a company, worldwide. Device and diagnostic studies usually have no phase.
Trials
777
in the 30 days to 2026-11-18
Added in 30 days
777
to 18 Nov 2026
Top country
United States
192 · 25% of the list
Phase covered
8
distinct values
Snapshot · 18 Nov 2026
Explore all 777 Growth
By month
777
Signals
What the register says this week, and why it matters if you sell into it.
- United States leads with 192 of 777, then China (171).
- 777 added in the 30 days to 18 Nov 2026.
- 174 of the listed studies are device, diagnostic or digital-health studies (no drug phase).
- A new trial needs sites, patients, data capture, monitoring and regulatory partners for years.
PostedSponsorStudyPhaseStatus
16 Nov 2026DALIM TISSEN Co., Ltd.South KoreaSafety and Efficacy of BioSeal as a Surgical Adhesive in Cardiovascular SurgeryNot applicableRecruiting16 Nov 2026DermaSensor, Inc.United StatesSkin Cancer Detection in Primary Care With and Without DermaSensorNot applicableNot Yet Recruiting16 Nov 2026Dexa Medica GroupIndonesiaThe Efficacy and Safety of DLBS1442 in Patients With Primary DysmenorrheaPhase 2, Phase 3Recruiting16 Nov 2026Dexa Medica GroupIndonesiaBioequivalence Study of Sitagliptin/Metformin 50 mg/1000 mg Extended Release TabletNot applicableCompleted16 Nov 2026Dexa Medica GroupIndonesiaThe Efficacy and Safety of DLBS3233 in Adults With PrediabetesPhase 3Completed16 Nov 2026DiproBio (Shanghai) Co., Ltd.ChinaEffects of Bifidobacterium Longum Subsp. Infantis i18 on Gut Microbiota Development and Health in Early LifeNot applicableNot Yet Recruiting16 Nov 2026DiproBio (Shanghai) Co., Ltd.ChinaEffects of a Combination of Bifidobacterium Longum Subsp. Longum Strains on Stress and Related Health Outcomes in Young AdultNot applicableNot Yet Recruiting16 Nov 2026Dr. August Wolff GmbH & Co. KG ArzneimittelBrazilNon-inferiority Study of a Hydroxyapatite and Calcium Hypophosphite Toothpaste Compared With Two Comparator Toothpastes in Dentin HypersensitivityNot applicableRecruiting16 Nov 2026Essilor InternationalUnited StatesEvaluation of the Espansione Equinox System Safety & Effectiveness for the Treatment of Meibomian Gland Dysfunction.Not applicableActive Not Recruiting16 Nov 2026Finzelberg GmbH & Co. KGGermany, IrelandEffects of a Botanical Extract on Cognitive Performance and Cerebral Blood Flow in Healthy AdultsNot applicableNot Yet Recruiting16 Nov 2026Geron CorporationA Trial Evaluating Two Imetelstat Doses in Participants With Lower Risk Myelodysplastic Syndrome (MDS)Phase 4Not Yet Recruiting16 Nov 2026Hanmi Pharmaceutical Company LimitedSouth KoreaA Study to Evaluate the Pharmacokinetics and Safety Between HIP2604 and RLD2606 in Healthy VolunteersPhase 1Not Yet Recruiting16 Nov 2026Hoffmann-La RocheA Study to Evaluate the Long-term Safety and Efficacy of Fenebrutinib in Participants With Multiple Sclerosis (MS)Phase 3Not Yet Recruiting16 Nov 2026Kanglin Biotechnology (Hangzhou) Co., Ltd.ChinaGene Therapy of Parkinson's Disease With KL002 in a Phase 1/2a Clinical StudyPhase 1, Phase 2Not Yet Recruiting16 Nov 2026Maxona Pharmaceuticals, Inc.United StatesA Study to Evaluate the Safety and Pain Relief of MAX-001 After Surgical Removal of Wisdom TeethPhase 2Not Yet Recruiting16 Nov 2026Merck Sharp & Dohme LLCA Study of V951A in Healthy Participants (V951A-001)Phase 1Not Yet Recruiting16 Nov 2026Nanjing Immunophage Biotech Co., LtdChinaA Study of IPG11406 Tablets in Participants With Lupus NephritisPhase 2Not Yet Recruiting16 Nov 2026Nordberg Medical ABJULÄINE™ - Neck Skin Laxity Clinical InvestigationNot applicableNot Yet Recruiting16 Nov 2026Novartis PharmaceuticalsA Study to Assess the Effect of Pacibekitug on Major Cardiovascular Events in Patients After a Myocardial InfarctionPhase 3Not Yet Recruiting16 Nov 2026Oneness Biotech Co., Ltd.Evaluating the Efficacy and Safety of Inhaled SNS812 in Hospitalized Adults With Moderate to Severe COVID-19Not applicableNot Yet Recruiting16 Nov 2026Polymedics Innovations Inc.AustriaInfluence of SUPRA SDRM on the Healing of Chronic WoundsNot applicableCompleted16 Nov 2026RAI Services CompanyUnited StatesVuse Pro Puffing Topography Study in Adult SmokersNot applicableRecruiting16 Nov 2026Shanghai Mabgeek Biotech.Co.LtdChinaMG-K10 in Pediatric Atopic Dermatitis (6-12 Years)Phase 1, Phase 2Not Yet Recruiting16 Nov 2026Shanghai Qilu Pharmaceutical Research and Development Center LTDA Phase I Study to Evaluate Single and Multiple Subcutaneous Administrations of QLS2406-1 Injection in Chinese Adult Participants With Overweight and Obesity.Phase 1Not Yet Recruiting16 Nov 2026Spinal Simplicity LLCCoverage With Evidence Development Study of Percutaneous Image-Guided Lumbar Decompression (PILD) With the Freedom DS Instrument System (FREEDOM-CED)Not Yet Recruiting16 Nov 2026Telios Pharma, Inc.United StatesTL-925 for the Treatment of Allergic ConjunctivitisPhase 2Not Yet Recruiting16 Nov 2026TuHURA Biosciences, Inc.A Study of TBS-2025 Monotherapy in Participants With r/r NPM1mut AMLPhase 1, Phase 2Not Yet Recruiting16 Nov 2026Vaderis Therapeutics AGPharmacokinetics of Engasertib in Participants With and Without Hepatic ImpairmentPhase 1Not Yet Recruiting16 Nov 2026ViiV HealthcareAn Evaluation of the Potential for VH4011499 Drug-drug-interactionsPhase 1Not Yet Recruiting13 Nov 2026AbbVieUnited StatesA Study to Assess the Adverse Events and How Oral ABBV-1606 Moves Through the Body of Healthy Adult Participants.Phase 1Not Yet Recruiting13 Nov 2026Aclaris Therapeutics, Inc.United StatesStudy of Modzatinib (ATI-2138) in Adult Participants With Biopsy-proven Forms of Lichen Planus Not Adequately Controlled With Topical TherapiesPhase 2Recruiting13 Nov 2026AstraZenecaAn Efficacy and Safety Study to Assess an Inhaled, Fixed-dose, Budesonide/Formoterol Fumarate in Participants Aged 4 to Less Than 12 Years of Age With Moderate Persistent AsthmaPhase 3Not Yet Recruiting13 Nov 2026CAMP4 Therapeutics CorporationArgentinaStudy of CMP-002 in Participants With SYNGAP1-Related DisorderPhase 1, Phase 2Not Yet Recruiting13 Nov 2026Changchun GeneScience Pharmaceutical Co., Ltd.ChinaClinical Trial of GenSci136 in Patients With Myasthenia GravisPhase 1, Phase 2Not Yet Recruiting13 Nov 2026Cutempa Medical AGGermanySilica-Based Wound Treatment (Curi01) Plus Standard Care Versus Standard Care Alone for Chronic Diabetic Foot WoundsNot applicableRecruiting13 Nov 2026DR Healthcare - biotexiaSpainEffect of Oral Diamine Oxidase on Symptoms Induced by Histamine Oral ChallengeNot applicableRecruiting13 Nov 2026Eli Lilly and CompanyUnited States, SingaporeA Study Assessing Eloralintide (LY3841136) in Healthy ParticipantsPhase 1Not Yet Recruiting13 Nov 2026Eli Lilly and CompanyUnited StatesA Study of Tersolisib (LY4064809) and Abemaciclib With Hormone Therapies in Participants With PIK3CA-Mutated Early Breast CancerPhase 2Not Yet Recruiting13 Nov 2026GC Biopharma CorpSouth KoreaPhase 2 Study of GC4006A in Healthy AdultsPhase 2Enrolling By Invitation13 Nov 2026Hangzhou Sciwind Biosciences Co., Ltd.ChinaA Phase I Study to Evaluate the Food Effect on Ecnoglutide TabletPhase 1Not Yet Recruiting13 Nov 2026Hemab ApSUnited StatesA Phase 3 Evaluation of Sutacimig in Glanzmann ThrombastheniaPhase 3Recruiting13 Nov 2026Hubei Bio-Pharmaceutical Industrial Technological Institute Inc.ChinaPhase I Study of HW281171 Tablets in Healthy ParticipantsPhase 1Not Yet Recruiting13 Nov 2026Jeil Pharmaceutical Co., Ltd.South KoreaObservational Study With Erosive Gastroesophageal Reflux Disease With JAQBO® ODTCompleted13 Nov 2026Korea United Pharm. Inc.South KoreaSafety and Pharmacokinetics of UI112 Compared With UIC202611 in Healthy AdultsPhase 1Not Yet Recruiting13 Nov 2026LembasUnited StatesEffects of a Gut-Active Peptide That Stimulates GLP-1 Release on Appetite and Satiety in Healthy Adults With OverweightNot applicableNot Yet Recruiting13 Nov 2026Nanjing Immunophage Biotech Co., LtdChinaStudy of IPG1094 Tablets in Chinese Healthy Adults and Obese AdultsPhase 1Not Yet Recruiting13 Nov 2026Novatek PharmaceuticalsA Multicenter Study Evaluating the Efficacy and Safety of Nivolumab and Ipilimumab in Combination With NP-101 Versus Placebo in Refractory Advanced and Metastatic Gastroenteropancreatic Neuroendocrine Carcinomas (GEP-NECs)Phase 2, Phase 3Not Yet Recruiting13 Nov 2026Priothera SASSingle and Multiple Ascending Dose Study of KRP-203 in Healthy Japanese AdultsPhase 1Completed13 Nov 2026RemeGen Co., Ltd.ChinaRC118 Combined With RC148 as First-Line Treatment for Claudin 18.2-Positive, HER2-Negative Advanced G/GEJ AdenocarcinomaPhase 2, Phase 3Not Yet Recruiting13 Nov 2026RemeGen Co., Ltd.ChinaIIIb Trial for RC28-E Injection in Participants With DME and wAMDPhase 3Not Yet Recruiting// How AOS uses this